Sculptor Capital’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $815K | Buy |
+308,600
| New | +$815K | 0.01% | 188 |
|
2025
Q1 | – | Sell |
-270,800
| Closed | -$693K | – | 258 |
|
2024
Q4 | $693K | Buy |
270,800
+53,000
| +24% | +$136K | 0.01% | 167 |
|
2024
Q3 | $810K | Buy |
217,800
+95,300
| +78% | +$355K | 0.01% | 155 |
|
2024
Q2 | $774K | Sell |
122,500
-143,700
| -54% | -$908K | 0.01% | 141 |
|
2024
Q1 | $1.43M | Buy |
266,200
+186,700
| +235% | +$1M | 0.03% | 117 |
|
2023
Q4 | $399K | Sell |
79,500
-51,800
| -39% | -$260K | 0.01% | 146 |
|
2023
Q3 | $222K | Hold |
131,300
| – | – | ﹤0.01% | 163 |
|
2023
Q2 | $365K | Buy |
131,300
+82,100
| +167% | +$228K | 0.01% | 157 |
|
2023
Q1 | $89.5K | Hold |
49,200
| – | – | ﹤0.01% | 256 |
|
2022
Q4 | $249K | Hold |
49,200
| – | – | ﹤0.01% | 399 |
|
2022
Q3 | $245K | Buy |
+49,200
| New | +$245K | ﹤0.01% | 575 |
|
2022
Q1 | – | Sell |
-153,300
| Closed | -$932K | – | 1119 |
|
2021
Q4 | $932K | Sell |
153,300
-4,800
| -3% | -$29.2K | 0.01% | 607 |
|
2021
Q3 | $1.54M | Hold |
158,100
| – | – | 0.01% | 447 |
|
2021
Q2 | $2.26M | Hold |
158,100
| – | – | 0.02% | 416 |
|
2021
Q1 | $3.75M | Buy |
158,100
+151,300
| +2,225% | +$3.59M | 0.03% | 285 |
|
2020
Q4 | $91K | Buy |
+6,800
| New | +$91K | ﹤0.01% | 365 |
|